Cargando…
Regulatory approval for COVID-19 across the globe
Autores principales: | Mahalmani, Vidya, Pugazhenthan, T, Mittal, Niti, Varthya, Shoban Babu, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092178/ https://www.ncbi.nlm.nih.gov/pubmed/33666185 http://dx.doi.org/10.4103/ijp.ijp_32_21 |
Ejemplares similares
-
Positive list of antibiotics and food products: Current perspective in India and across the globe
por: Mahalmani, Vidya M., et al.
Publicado: (2019) -
Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak
por: Mahalmani, Vidya, et al.
Publicado: (2021) -
Do alternatives to animal experimentation replace preclinical research?
por: Mahalmani, Vidya, et al.
Publicado: (2023) -
Named terminologies of patient-centered – A focus respective to stigmatized disease
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020) -
Target/therapies for chronic recurrent erythema nodosum leprosum
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)